Bristol Myers Squibb Patient Assistance Foundation
Run by Bristol-Myers Squibb Company
Bristol Myers Squibb Patient Assistance Foundation, run by Bristol-Myers Squibb Company, provides the medication at no cost if you qualify. One eligibility path: "Your insurance doesn't cover this medicine."
At a glance
- Run by
- Bristol-Myers Squibb Company
- Status
- Verified
- Last verified
- 08/19/26
- Medicare
- Has a Medicare eligibility path.
- Confirmed medications
- 1
- Coverage unconfirmed
- 25
Phone 1-800-736-0003
Income limits and eligibility paths
Review each published path and its conditions. A path may apply only to certain medications or insurance coverage.
Your insurance doesn't cover this medicine
RESOLVED for Eliquis and Orencia specifically: $47,880 (household 1) / $64,920 (household 2), adjusted for larger families (exact schedule beyond household size 2 not printed). The other 23 drug families have an income-EXEMPT path for certain cancer/autoimmune/cardiomyopathy/transplant indications -- see the 'income-exempt-condition' track.
Income basis
Published household amounts
Confirm the table’s geographic applicability and larger-household rules with the program.
You have Medicare and spend a lot on prescriptions
No separate income test beyond the 3%-out-of-pocket documentation itself; this track substitutes a spending test for an income test.
Income basis
Published household amounts
Confirm the table’s geographic applicability and larger-household rules with the program.
You have a qualifying serious condition, regardless of income
There is no income limit for this track — you may qualify even if your income is higher than the limits listed above. It applies to the 23 drug families outside Eliquis and Orencia, covering cancer, ulcerative colitis, multiple sclerosis, plaque psoriasis, obstructive hypertrophic cardiomyopathy and kidney transplant. The full qualifying rules are in the program's own Start Assessment tool.
Income basis
Published household amounts
Confirm the table’s geographic applicability and larger-household rules with the program.
Insurance and other requirements
Each path has its own conditions. Read the complete requirements and confirm which path applies to you.
-
Path 1
Your insurance doesn't cover this medicine
Insurance category: no-insurance
- ·RESOLVED for Eliquis and Orencia specifically: $47,880 (household 1) / $64,920 (household 2), adjusted for larger families (exact schedule beyond household size 2 not printed). The other 23 drug families have an income-EXEMPT path for certain cancer/autoimmune/cardiomyopathy/transplant indications -- see the 'income-exempt-condition' track.
-
Path 2
You have Medicare and spend a lot on prescriptions
Insurance category: medicare
- ·No separate income test beyond the 3%-out-of-pocket documentation itself; this track substitutes a spending test for an income test.
- ·Must document at least 3% of annual household income spent out-of-pocket on prescriptions in the same calendar year as applying (re-required at annual renewal).
- ·Age 65+ patients must show proof of denial for Medicare Part D Low-Income Subsidy (LIS/Extra Help).
-
Path 3
You have a qualifying serious condition, regardless of income
Insurance category: any
- ·There is no income limit for this track — you may qualify even if your income is higher than the limits listed above. It applies to the 23 drug families outside Eliquis and Orencia, covering cancer, ulcerative colitis, multiple sclerosis, plaque psoriasis, obstructive hypertrophic cardiomyopathy and kidney transplant. The full qualifying rules are in the program's own Start Assessment tool.
- ·Applies only to cancer, ulcerative colitis, multiple sclerosis, plaque psoriasis, obstructive hypertrophic cardiomyopathy, or kidney transplant indications (not Eliquis/Orencia, which use the standard income-tested tracks above).
What this program covers
1 confirmed covered, 7 documented exclusions and 25 unconfirmed associations. Check the category before relying on a medication link.
Covered medications
- Zenbexus Covered · 08/19/26
Confirmed covered associations. The program’s eligibility rules still apply.
Not on this program's current list
- Abecma Not covered · 08/19/26
- Azactam Not covered · 08/19/26
- Baraclude Not covered · 08/19/26
- Evotaz Not covered · 08/19/26
- Halog Not covered · 08/19/26
- Triesence Not covered · 08/19/26
- Reyataz Not covered · 08/19/26
These exclusions refer to this program only. They do not prove that all other help is unavailable.
Coverage unconfirmed
- Abraxane Unknown
- Augtyro Unknown
- Camzyos Unknown
- Cobenfy Unknown
- Eliquis Unknown
- Empliciti Unknown
- Idhifa Unknown
- Inrebic Unknown
- Istodax Unknown
- Krazati Unknown
- Nulojix Unknown
- Onureg Unknown
- Opdivo Unknown
- Opdivo Qvantig Unknown
- Opdualag Unknown
- Orencia Unknown
- Pomalyst Unknown
- Reblozyl Unknown
- Revlimid Unknown
- Sotyktu Unknown
- Sprycel Unknown
- Thalomid Unknown
- Vidaza Unknown
- Yervoy Unknown
- Zeposia Unknown
Our records link these medications to this program, but we do not have enough evidence to confirm coverage. Contact the program before relying on this association.
How to apply
Continue to the official program website ↗
Use the program’s official application. Required documents, approval periods and renewal rules vary.
Keep your approval notice. It explains when assistance ends and what to do if renewal is required.
-
1
Check the official application
Confirm medication coverage and the eligibility path that fits your situation.
-
2
Gather the required documents
Use the income and insurance documents requested by the current form.
-
3
Coordinate with your prescriber
Ask whether clinical information, a prescription or a signature is required.
-
4
Submit and follow up
Confirm receipt and ask about the decision, approval period and renewal rules.
If this is more than you want to take on
Help with the application paperwork
You can follow the official application instructions yourself. If you choose paid help, ask which documents and follow-up tasks the fee includes.
Compare current pricing, cancellation terms and available reviews. Paying for paperwork does not establish eligibility or guarantee approval.
- Ask which forms the service prepares and submits
- Ask how the service works with your prescriber
- Check whether renewal assistance is included
Paid paperwork help is optional. Confirm the official program’s requirements first.
What changed
Changes to this program’s rules, from newest to oldest, based on its published information.
08/19/26 ZENBEXUS (iberdomide) is now listed among the medicines available through the Bristol Myers Squibb Patient Assistance Foundation.
08/19/26 Medicare patients applying to the Bristol Myers Squibb Patient Assistance Foundation must also show they spent at least 3% of their annual household income on out-of-pocket prescription costs in the year they apply. This is in addition to the program's income limits.
Documents we track
Program document
Available on the program’s official website, last checked 08/19/26. Confirm current requirements at: https://www.bmspaf.org/.
This link points to the program’s own document. Check the record’s verification status and confirm current terms.
What changed on this record
Bristol Myers Squibb Patient Assistance Foundation requirements read and verified; tracking began.
ZENBEXUS (iberdomide) is now listed among the medicines available through the Bristol Myers Squibb Patient Assistance Foundation.
Medicare patients applying to the Bristol Myers Squibb Patient Assistance Foundation must also show they spent at least 3% of their annual household income on out-of-pocket prescription costs in the year they apply. This is in addition to the program's income limits.